A-lister Oprah Winfrey recently revealed that her opinion on "thin people" has dramatically changed since starting her weight ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...

Concern is growing among Democrats after President Donald Trump reversed some of the former president’s executive orders, ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side ...

Ozempic itself is a metonym for weight loss drugs. All of this makes the drug tricky because most people would not classify simple weight loss as a good reason to take it. Ozempic exists ...

That’s largely because the country is home to Novo Nordisk, the maker of Ozempic and Wegovy, the popular weight-loss drugs. The company is so important to the Danish economy — it has recently ...

AS HOLIDAY TREATS GIVE WAY TO NEW YEAR’S RESOLUTIONS, the names of GLP-1 weight-loss drugs like Ozempic and Wegovy will be on millions of lips this January—in addition to any leftover fruitcake, ...

Nikki Glaser accurately called the 82nd Annual Golden Globe Awards "Ozempic's biggest night." (Sonja Flemming/CBS via Getty Images) ...